84341-13-9

Basic information

• Product Name: 8-chloro-3H-pyrido[3,4-d]pyrimidin-4-one
• Synonyms: 8-chloro-3H-pyrido[3,4-d]pyrimidin-4-one;8-CHLORO-3H,4H-PYRIDO[3,4-D]PYRIMIDIN-4-ONE;8-CHLOROPYRIDO[3,4-D]PYRIMIDIN-4-OL
• CAS NO: 84341-13-9
• Molecular Formula: C7H4ClN3O
• Molecular Weight: 181.57916
• Mol File: 84341-13-9.mol
• Article Data: 6

Chemical Properties

• Melting Point: 259-260 °C(Solv: ethanol (64-17-5))
• Boiling Point: 368.3±52.0 °C(Predicted)
• Appearance: /
• Density: 1.66±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -0.57±0.20(Predicted)
• CAS DataBase Reference: 8-chloro-3H-pyrido[3,4-d]pyrimidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 8-chloro-3H-pyrido[3,4-d]pyrimidin-4-one(84341-13-9)
• EPA Substance Registry System: 8-chloro-3H-pyrido[3,4-d]pyrimidin-4-one(84341-13-9)

Safety Data

• Hazardous Substances Data: 84341-13-9(Hazardous Substances Data)

Usage

General Description

8-chloro-3H-pyrido[3,4-d]pyrimidin-4-one is a chemical compound that belongs to the class of pyrido[3,4-d]pyrimidin-4-one derivatives. It is a heterocyclic compound containing both a pyridine and a pyrimidine ring, as well as a chlorine atom at the 8th position. 8-chloro-3H-pyrido[3,4-d]pyrimidin-4-one has potential applications in medicinal chemistry, particularly in the development of new pharmaceuticals and agrochemicals. Its unique structure and properties make it an interesting target for further research and development. Additionally, its chlorine substitution may confer specific biological activities and potential therapeutic benefits, making it a promising candidate for further investigation.

Upstream product

• 58483-94-6 3-amino-2-chloroisonicotinic acid 
• 463-52-5 formamidine 
• 342899-34-7 3-amino-2-chloropyridine-4-carboxamide 
• 173435-41-1 methyl 3-amino-2-chloropyridine-4-carboxylate 
• 122-51-0 orthoformic acid triethyl ester 
• 77287-34-4 formamide 
• 1312105-89-7 3-((tert-butoxycarbonyl)amino)-2-chloroisonicotinic acid 
• 209798-48-1 tert-butyl N-(2-chloro-3-pyridinyl)carbamate 
• 6298-19-7 2-chloro-3-aminopyridine 

Downstream Products

• 1260663-37-3 4,8-dichloropyrido[3,4-d]pyrimidine 

Relevant articles and documents

BICYCLIC ETHER O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS

Described herein are compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and using the same. The variables Ar, X, R1, R3, R 4, Y1, Y2, n and p are as defined herein.

WNT SIGNALING INHIBITOR

A Wnt signaling inhibitor which comprises, as an active ingredient, a fused-ring heterocyclic compound represented by the following formula (IA) or a pharmaceutically acceptable salt thereof, and the like are provided: (wherein, n1A represents

HISTONE DEMETHYLASE INHIBITORS

The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrido[3,4-d]pyrimidin-4-one derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like